Russell Kern
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-04-25–present
-
Current
2008-01-01–present
-
International Stem Cell CORP (ISCO)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | International Stem Cell CORP (ISCO) | — | $260,000 | $370,000 |
| 2024 | International Stem Cell CORP (ISCO) | — | $260,000 | $260,000 |
| 2023 | International Stem Cell CORP (ISCO) | — | $140,000 | $377,237 |
| 2022 | International Stem Cell CORP (ISCO) | — | $106,440 | $439,943 |
| 2021 | International Stem Cell CORP (ISCO) | — | $58,096 | $125,893 |
| 2020 | International Stem Cell CORP (ISCO) | — | $53,968 | $53,968 |
| 2019 | International Stem Cell CORP (ISCO) | — | $40,501 | $166,320 |
| 2018 | International Stem Cell CORP (ISCO) | — | $59,604 | $325,621 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.